title: Quality, safety and sustained therapeutic efficacy of blood-derived serum eye drops to treat dry eye syndrome: R&D road map for future progress.
authors.affiliation: International Consultancy in Blood Components Quality/Safety, Audit/Inspection and DDR Strategies, London, UK. Electronic address: jseghatchian@btopenworld.com.
authors.forename: Jerard
authors.initials: J
authors.lastname: Seghatchian
authors.affiliation: Department of Immunology and Transfusion Medicine, St. Olav's University Hospital, Trondheim, Norway.
authors.forename: Aurora
authors.initials: A
authors.lastname: Espinosa
authors.affiliation: Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.
authors.forename: Thierry
authors.initials: T
authors.lastname: Burnouf
mesh_terms: D015352:Dry Eye Syndromes / Q000188:drug therapy*; D006801:Humans; D009883:Ophthalmic Solutions / Q000592:standards* / Q000627:therapeutic use*; D012106:Research; D012449:Safety; D044967:Serum / Q000378:metabolism*; D016896:Treatment Outcome
chemical_list: D009883:Ophthalmic Solutions
keywords: Dry eye syndromes; Quality/safety standard of SED; Sustained therapeutic efficacy of SED